metastatic breast cancer

presented by

Diagnostics company uses epigenetics principles to develop metastatic breast cancer test

Women with breast cancer virtually never die from their primary tumor. Rather, the vast majority – nearly 90 percent – of solid tumor deaths happen because it’s metastasized through the blood, said Oscar Bronsther, CEO of diagnostics company MetaStat. The company is developing diagnostics for metastatic breast cancer, so physicians can determine whether surgery and local radiation will suffice […]